While still a couple of years out, MD+DI gained some insights into Dexcom's next-generation sensor from an interview with the ...

San Diego, California-based DexCom, Inc. (DXCM) is a medical device company that designs, develops, and commercializes ...

DexCom recently reported preliminary, unaudited results showing fourth-quarter 2025 revenue of about US$1.26 billion and full-year 2025 revenue of roughly US$4.66 billion, both rising at double-digit ...

"JPM26: Dexcom’s new CEO eyes international CGM markets for 2026 growth" was originally created and published by Medical ...

In his inaugural J.P. Morgan Healthcare Conference speech, newly minted Dexcom CEO Jake Leach looked to ease concerns over ...

The global sensor patch market revenue was around US$ 2.2 billion in 2023 and is estimated to reach US$ 56.4 billion by 2032, growing at a compound annual growth rate (CAGR) of 43.2% during the ...

The smart home has been drifting into a world of interoperability lately that I never would have expected just a few years ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

DexCom, Inc. , the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose monitoring (CGM) market. A strong third-quarter 2025 performance and a series ...